NCT03079557View on ClinicalTrials.gov

Feasibility Pilot for the ReBOO-trial

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Obesity
Interventions
DRUG

Intragastric botulinum toxin type A

200 units Botulinum toxin A (Allergan) injected intragastrically in the antrum every six months

Trial Locations (1)

Unknown

St Olavs Hospital Trondheim University Hospital, Trondheim

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

St. Olavs Hospital

OTHER

NCT03079557 - Feasibility Pilot for the ReBOO-trial | Biotech Hunter | Biotech Hunter